Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers.

Dorsey ER, Achey MA, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Ziman N, Aldred J, Carter J, Jimenez-Shahed J, Hunter C, Spindler M, Mari Z, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Bull MT, Mejia NI, Bwala G, Nance M, Shih L, Anderson L, Singer C, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Cooper J, Webb S, Dhall R, Hassan A, Weis D, DeMello S, Riggare SS, Wicks P, Smith J, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W.

Telemed J E Health. 2016 Jul;22(7):590-8. doi: 10.1089/tmj.2015.0191.

PMID:
26886406
2.

Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials.

Lang AE, Rodriguez RL, Boyd JT, Chouinard S, Zadikoff C, Espay AJ, Slevin JT, Fernandez HH, Lew MF, Stein DA, Odin P, Fung VS, Klostermann F, Fasano A, Draganov PV, Schmulewitz N, Robieson WZ, Eaton S, Chatamra K, Benesh JA, Dubow J.

Mov Disord. 2016 Apr;31(4):538-46. doi: 10.1002/mds.26485.

3.

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.

NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators..

Lancet Neurol. 2015 Aug;14(8):795-803. doi: 10.1016/S1474-4422(15)00144-1. Erratum in: Lancet Neurol. 2015 Oct; 14(10):979.

4.

Is There a Role for DAT-SPECT Imaging in a Specialty Movement Disorders Practice?

Bega D, Gonzalez-Latapi P, Zadikoff C, Spies W, Simuni T.

Neurodegener Dis. 2015;15(2):81-6. doi: 10.1159/000370116.

PMID:
25592727
5.

Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patients.

Slevin JT, Fernandez HH, Zadikoff C, Hall C, Eaton S, Dubow J, Chatamra K, Benesh J.

J Parkinsons Dis. 2015;5(1):165-74. doi: 10.3233/JPD-140456.

PMID:
25588353
6.

Complementary & alternative management of Parkinson's disease: an evidence-based review of eastern influenced practices.

Bega D, Zadikoff C.

J Mov Disord. 2014 Oct;7(2):57-66. doi: 10.14802/jmd.14009. Review.

7.

A review of the clinical evidence for complementary and alternative therapies in Parkinson's disease.

Bega D, Gonzalez-Latapi P, Zadikoff C, Simuni T.

Curr Treat Options Neurol. 2014 Oct;16(10):314. doi: 10.1007/s11940-014-0314-5.

PMID:
25143234
8.

The development and implementation of the Chicago public schools emergency EpiPen® policy.

Zadikoff EH, Whyte SA, Desantiago-Cardenas L, Harvey-Gintoft B, Gupta RS.

J Sch Health. 2014 May;84(5):342-7. doi: 10.1111/josh.12147.

PMID:
24707929
9.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators., Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
10.

Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.

Videnovic A, Noble C, Reid KJ, Peng J, Turek FW, Marconi A, Rademaker AW, Simuni T, Zadikoff C, Zee PC.

JAMA Neurol. 2014 Apr;71(4):463-9. doi: 10.1001/jamaneurol.2013.6239.

11.

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A; LCIG Horizon Study Group..

Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Erratum in: Lancet Neurol. 2014 Mar;13(3):240.

12.
13.

Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.

Li S, Wu Y, Keating SM, Du H, Sammet CL, Zadikoff C, Mahadevia R, Epstein LG, Ragin AB.

J Neurovirol. 2013 Oct;19(5):452-60. doi: 10.1007/s13365-013-0197-3.

14.

Deep brain stimulation improves movement amplitude but not hastening of repetitive finger movements.

Stegemöller EL, Zadikoff C, Rosenow JM, Mackinnon CD.

Neurosci Lett. 2013 Sep 27;552:135-9. doi: 10.1016/j.neulet.2013.07.056.

PMID:
23941889
15.

Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease.

Reginold W, Duff-Canning S, Meaney C, Armstrong MJ, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Marshall F, Mapstone M, Chou KL, Persad C, Litvan I, Mast B, Tang-Wai D, Lang AE, Marras C.

Dement Geriatr Cogn Disord. 2013;36(1-2):67-75. doi: 10.1159/000350032.

PMID:
23774742
16.

Implicit perceptual-motor skill learning in mild cognitive impairment and Parkinson's disease.

Gobel EW, Blomeke K, Zadikoff C, Simuni T, Weintraub S, Reber PJ.

Neuropsychology. 2013 May;27(3):314-21. doi: 10.1037/a0032305.

17.

Clinical Reasoning: a woman with rapidly progressive apraxia.

Pressman P, Bigio EH, Gitelman D, Zadikoff C.

Neurology. 2013 Apr 9;80(15):e162-5. doi: 10.1212/WNL.0b013e31828c2eb8. No abstract available.

18.

Measuring mild cognitive impairment in patients with Parkinson's disease.

Marras C, Armstrong MJ, Meaney CA, Fox S, Rothberg B, Reginold W, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Kennedy N, Marshall FJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Duff-Canning S.

Mov Disord. 2013 May;28(5):626-33. doi: 10.1002/mds.25426.

19.

Amantadine for freezing of gait in patients with Parkinson disease.

Malkani R, Zadikoff C, Melen O, Videnovic A, Borushko E, Simuni T.

Clin Neuropharmacol. 2012 Nov-Dec;35(6):266-8. doi: 10.1097/WNF.0b013e31826e3406.

Items per page

Supplemental Content

Loading ...
Support Center